Clinical Neuropsychologist Online
  • Clinical Neuropsychologist
    • Neuropsychological Assessment
      • What is Clinical Neuropsychology?
      • Our Clinical Neuropsychology Consults
        • Post-COVID Neuropsychological Assessment
    • Our Clinical Neuropsychologist
      • Clinical Neuropsychologist Referral
      • Clinical Neuropsychology Intake Upload
    • Clinical Neuropsychologist Online Appointments
      • Intake Appointment
      • Neuropsychologist Consult
      • Neuropsychology Feedback Session
  • Neuropsychology Knowledgebase
    • Acquired Brain Injury
    • Alzheimer’s Disease Neuropsychology
    • COVID-19 Neuropsychology
    • Dementia Neuropsychology
    • Memory Neuropsychology
    • Neuroanatomy & Neuroradiology
    • Neuropsychological Assessment
    • Neuropsychological Disorders
    • Psychometrics in Neuropsychology
  • Neuropsychology CPD
    • Latest Journal Articles
    • Cognitive Neuropsychology
    • Dementia
    • Neuro Podcasts
    • Neuroimaging
    • Neuropsychology (general)
    • Neurorehabilitation
    • Neuroscience
    • Paediatric Neuropsychology
  • Neuropsychology Courses
  • Newsletter
  • Brain Lounge
Select Page

500. Family Business: The Journey to 500 Episodes w/ Carrie Haynes, LPC (my wife)

by Clinical Neuropsychologist | Thursday, March 27, 2025 | Neuro Podcasts

Would you rather read the transcript? Click here. Making it to 500 episodes is no joke, and I couldn’t have done it without the support of my amazing partner, Carrie. A therapist and podcaster herself, she has encouraged and challenged me countless times along the...

Pathways underlying selective neuronal vulnerability in Alzheimer’s disease: Contrasting the vulnerable locus coeruleus to the resilient substantia nigra

by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia

Abstract INTRODUCTION Alzheimer’s disease (AD) selectively affects certain brain regions, yet the mechanisms of selective vulnerability remain poorly understood. The neuromodulatory subcortical system, which includes nuclei exhibiting a range of vulnerability...

Semiautomatic Quantification of 99mTc‐TRODAT‐1 SPECT Images in Patients With Idiopathic Parkinson’s Disease

by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Neuroimaging

ABSTRACT Background and Purpose 99mTc-TRODAT-1 SPECT imaging is an imaging technique, more commonly used in Asia, to diagnose Parkinson’s disease (PD). This study evaluates the use of automated three-dimensional volume-of-interest (VOI) analysis in diagnosing...

Generalizability of tau and amyloid plasma biomarkers in Alzheimer’s disease cohorts of diverse genetic ancestries

by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia

Abstract INTRODUCTION Plasma phosphorylated threonine 181 of tau (pTau181) and amyloid beta (Aβ) are biomarkers for differential diagnosis and preclinical detection of Alzheimer disease (AD). Given differences in AD risk across diverse populations,...

Blood DNA methylation signature for incident dementia: Evidence from longitudinal cohorts

by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia

Abstract INTRODUCTION Distinguishing between molecular changes that precede dementia onset and those resulting from the disease is challenging with cross-sectional studies. METHODS We studied blood DNA methylation (DNAm) differences and incident dementia in two large...
« Older Entries
Next Entries »

Posts by Category

  • Cognitive Neuropsychology
  • Dementia
  • Neuro Podcasts
  • Neuroimaging
  • Neuropsychology (general)
  • Neurorehabilitation
  • Neuroscience
  • Paediatric Neuropsychology

Neuropsychology Newsletter &
Interest List

S U B S C R I B E

  • X
  • RSS
© PsyAsia Neuropsychology. Clinical Neuropsychologist Hong Kong & Online. Part of the Psychology1 Group. All Rights Reserved.
DISCLAIMER: We are not responsible for any inaccuracies at this site. No medical advice is being offered to you personally.
No medical contract is formed by you visiting PsyAsia Neuropsychology.